Pluri Inc. (TLV:PLUR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,804.00
-12.00 (-0.66%)
Aug 25, 2025, 6:24 PM IDT
-0.66%
Market Cap150.61M
Revenue (ttm)3.85M
Net Income (ttm)-77.13M
Shares Outn/a
EPS (ttm)-13.44
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,324
Average Volume4,931
Open1,816.00
Previous Close1,816.00
Day's Range1,725.00 - 1,830.00
52-Week Range1,299.00 - 2,345.00
Betan/a
RSI57.26
Earnings DateSep 12, 2025

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acut... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 118
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PLUR
Full Company Profile

Financial Performance

In 2024, Pluri's revenue was $326,000, an increase of 13.59% compared to the previous year's $287,000. Losses were -$20.89 million, -26.25% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.